Clearmind Medicine Inc
For the period ended Oct 31, 2023. Filed Jan 29, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Jan 29, 2024
CMND$5.58-4.6%Stored close · as of Nov 6, 2026
Contents
Significant Changes
B. Significant Changes
Other than as otherwise described in this Annual Report on Form 20-F and as set forth below, no significant change has occurred in our operations since the date of our financial statements included in this Annual Report on Form 20-F.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.